Skip to main content

Life Tech Partners with DaAn to Bring Sanger-Based Dx to Chinese Market

Premium

Life Technologies is partnering with DaAn Gene, a Chinese molecular in vitro diagnostics company, to form Life Technologies DaAn Diagnostics.

Based in Guangzhou, the company will develop and commercialize a suite of assays using Life Tech's 3500Dx capillary electrophoresis instrument and the Big Dye Cycle Sequencing technologies. Life Tech's 3500Dx was approved by the China State Food and Drug Administration for IVD use last October.

The new company will aim develop IVD assays for oncology, infectious diseases, and genetic diseases.

Life Tech's CEO Greg Lucier said in a statement that the venture "represents a big leap forward for our business in China."

The venture is also an extension of a partnership that formed 20 years ago between Life Tech predecessor Applied Biosystems and DaAn, which brought PCR-based diagnostics to China.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.